Bristol-Myers Squibb locks into novel autoimmune strategy.
Ken
K
Garber
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D015195:Drug Design; D004345:Drug Industry / Q000639:trends*; D013678:Technology, Pharmaceutical / Q000639:trends*
D000893:Anti-Inflammatory Agents